You have no items in your shopping cart.
0item(s)
You have no items in your shopping cart.
CJC 1295 without DAC (Drug Affinity Complex) is a synthetic peptide designed to stimulate the natural release of growth hormone (GH) from the pituitary gland. This peptide is a modified form of Growth Hormone-Releasing Hormone (GHRH), tailored to deliver targeted and short-term GH secretion, making it ideal for controlled research applications.
Key Features:
Mechanism of Action: CJC 1295 without DAC works by mimicking the function of endogenous GHRH. Upon administration, it binds to specific receptors in the pituitary gland, triggering the release of growth hormone. This short-acting nature ensures a rapid but temporary GH surge, closely resembling the body’s natural growth hormone release patterns.
Applications in Research:
Specifications:
Why Choose CJC 1295 Without DAC? CJC 1295 without DAC is favored for its precision and adaptability in research settings. Its shorter action window allows researchers to observe distinct GH pulses and their effects without prolonged interference, making it an invaluable tool for advanced peptide studies.
Important Note:
CJC 1295 without DAC is intended for research and laboratory use only. It is not approved for human consumption or therapeutic use. Always handle peptides with care and store them as recommended to maintain integrity.